封面
市场调查报告书
商品编码
1402584

蛋白质定序市场:按技术、按产品、按应用、按最终用户、按地区

Protein Sequencing Market, By Technology, By Product, By Application, By End User, By Region

出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

蛋白质定序市场规模预计将从 2023 年的 19 亿美元增加到 2030 年的 42.2 亿美元,预测期内复合年增长率为 12.1%。

报告范围 报告详情
基准年 2022年 2023年市场规模 19亿美元
实际资料 2018-2021 预测期 2023-2030
预测期复合年增长率 12.10% 2030年市场规模预测 42.2亿美元
图 1. 2023 年蛋白质定序全球市场占有率(%)(按地区)
蛋白质定序市场-IMG1

蛋白质定序是生物化学和分子生物学领域用于确定蛋白质中胺基酸顺序的重要技术。这个过程有助于理解各种生物过程所必需的蛋白质的结构和功能。蛋白质定序在药物研究、生物技术和个人化医疗中发挥重要作用。

由于对蛋白质疗法的需求不断增加、蛋白质体学研究的进步以及慢性病盛行率的上升,全球蛋白质定序市场正在显着成长。此外,对精准医疗和个体化治疗的日益关注也推动了市场成长。例如,2023年9月12日,专门从事蛋白质体学加速的公司Olink Holding AB宣布与Eurofins Scientific Group旗下子公司Eurofins Genomics建立合作伙伴关係,透过Olink的应用开发研究、人口和人口技术该公司宣布将加强其在健康和监管临床试验领域的产品和服务。

同样,2022 年 3 月,下一代药物研发和药物开发蛋白质组学解决方案的领导者 Biognosys 将为製药和诊断客户提供从早期发现到临床环境的整个研发开发平臺。一套蛋白质组学平台,可在全球范围内提供深入的生物学见解。

市场动态:

蛋白质定序市场由多种因素驱动。首先,癌症、心血管疾病和神经系统疾病等慢性疾病的日益普及增加了对蛋白质疗法的需求。蛋白质序列在药物研发发现和开发中发挥关键作用,使研究人员能够了解疾病机制并开发标靶治疗。例如,根据美国疾病管制与预防中心发布的资料,据估计,美国有超过七分之一的成年人(约3,550万人,即14%)患有慢性肾臟病(CKD)。 CKD 在 65 岁及以上人群中更为常见 (34%),而在 45 至 64 岁人群 (12%) 和 18 至 44 岁人群中 (6%) 更常见。

此外,蛋白质体学研究的进步正在为蛋白质定序市场创造新的机会。质谱和次世代定序等高通量技术的发展彻底改变了蛋白质体学领域,使蛋白质定序变得更加容易和高效。

但蛋白质定序市场也面临挑战与抑制因素。蛋白质定序设备和试剂的高成本是市场成长的主要抑制因素之一。此外,蛋白质结构的复杂性和可变性对准确可靠的蛋白质定序提出了技术挑战。

也就是说,蛋白质定序市场存在一些成长机会。对研发活动的投资增加,特别是在新兴经济体,可能会为市场相关人员带来新的前景。此外,对个人化医疗和标靶治疗日益增长的需求预计将推动未来对蛋白质定序的需求。

本研究的主要特点

  • 本报告对全球蛋白质定序市场进行了详细分析,包括以2022年为基准年的预测期(2023-2030)的市场规模和复合年增长率。
  • 发现不同细分市场的潜在商机,并向相关人员提供一系列有吸引力的投资提案。
  • 它提供了蛋白质定序市场主要企业所采用的市场驱动因素、抑制因素、市场机会、市场趋势和竞争策略的重要考察。
  • 我们根据公司亮点、产品系列、财务表现和策略等参数对全球蛋白质定序市场的主要企业进行了分析。
  • 主要公司包括 Agilent Technologies、Thermo Fisher Scientific、SGS SA、Shimadzu Corp、Waters Corp、Bio-Rad Laboratories、Bruker Corporation、Charles River Laboratories、Selvita 和 Rapid Novor Inc。
  • 该研究报告使行销人员和管理负责人能够就未来的产品发布、市场扩张和行销策略做出明智的决策。
  • 蛋白质定序产业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师,都可以从所提供的见解中受益。
  • 用于分析全球蛋白质定序市场的策略矩阵可帮助相关人员做出明智的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 增加蛋白质体学研究的投资
    • 抑制因素
    • 蛋白质序列测定设备和服务成本高
    • 机会
    • 新兴国家呈现巨大成长机会
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章蛋白质定序市场-冠状病毒(COVID-19)大流行的影响

  • 新型冠状病毒感染疾病(COVID-19)的流行病学
  • 供需面分析
  • 经济影响

第 5 章 2018-2030 年蛋白质定序市场(依技术)

  • 艾德曼劣化
  • 质谱
  • 其他的

第 6 章 蛋白质定序市场(依产品),2018-2030

  • 工具
  • 试剂、套件及耗材
  • 软体和服务

第 7 章 2018-2030 年蛋白质定序市场(依应用)

  • 学术研究
  • 临床诊断
  • 生物製药
  • 其他的

第 8 章 蛋白质定序市场,依最终使用者划分,2018-2030 年

  • 製药和生物技术公司
  • 学术研究所
  • 合约研究组织

第 9 章 2018-2030 年蛋白质定序市场(按地区)

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争形势

  • Agilent Technologies
  • Thermo Fisher Scientific
  • SGS SA
  • Shimadzu Corp
  • Waters Corp.
  • Bio-Rad Laboratories
  • Bruker Corporation
  • Charles River Laboratories
  • Selvita
  • Rapid Novor Inc.

第11章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6507

The protein sequencing market size is expected to reach US$ 4.22 billion by 2030, from US$ 1.90 billion in 2023, at a CAGR of 12.1% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 1.90 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 12.10% 2030 Value Projection: US$ 4.22 Bn
Figure 1. Global Protein Sequencing Market Share (%), by Region, 2023
Protein Sequencing Market - IMG1

Protein sequencing is a crucial technique used in the field of biochemistry and molecular biology to determine the order of amino acids in a protein. This process helps in understanding the structure and function of proteins, which are essential in various biological processes. Protein sequencing plays a significant role in pharmaceutical research, biotechnology, and personalized medicine.

The global protein sequencing market has been witnessing significant growth due to the increasing demand for protein-based therapeutics, advancements in proteomics research, and the rising prevalence of chronic diseases. Moreover, the increasing focus on precision medicine and personalized treatments is also driving the market growth. For instance, on September 12 2023, Olink Holding AB, a company dedicated to accelerating proteomics, announced the collaboration with Eurofins Genomics, a division of Eurofins Scientific Group, to bolster its offerings in the fields of research, population health, and regulated clinical trials through the application of Olink technology.

Similarly, in March 2022, Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced the launch of its expanded suite of proteomics platforms that provide pharmaceutical and diagnostics customers with deep biological insights across the entire R&D pipeline, from early stage discovery to clinical settings.

Market Dynamics:

The protein sequencing market is driven by several factors. Firstly, the growing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, has led to an increased demand for protein-based therapies. Protein sequencing plays a critical role in drug discovery and development, enabling researchers to understand the mechanisms of diseases and develop targeted therapies. For instance, according to data published by Centers for Disease Control and Prevention, more than 1 in 7 US adults-about 35.5 million people, or 14%-are estimated to have Chronic Kidney Disease (CKD). CKD is more common in people aged 65 years or older (34%) than in people aged 45-64 years (12%) or 18-44 years (6%).

Additionally, the advancements in proteomics research have opened up new opportunities for the protein sequencing market. The development of high-throughput technologies, such as mass spectrometry and next-generation sequencing, has revolutionized the field of proteomics, making protein sequencing more accessible and efficient.

However, there are certain challenges and restraints faced by the protein sequencing market. The high cost of protein sequencing instruments and reagents is one of the major hindrances to the market growth. Moreover, the complexity and variability of protein structures pose technical challenges in accurate and reliable protein sequencing.

Nevertheless, the protein sequencing market presents several opportunities for growth. The increasing investment in research and development activities, particularly in emerging economies, is likely to create new prospects for market players. Additionally, the rise in personalized medicine and the need for targeted therapies are expected to drive the demand for protein sequencing in the future.

Key Features of the Study:

  • This report provides in-depth analysis of the global protein sequencing market, including market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year.
  • It elucidates potential revenue opportunities across different market segments and presents attractive investment proposition matrices for stakeholders.
  • The study provides key insights into market drivers, restraints, opportunities, market trends, and competitive strategies adopted by key players in the protein sequencing market.
  • Key players in the global protein sequencing market are profiled based on parameters such as company highlights, product portfolios, financial performance, and strategies.
  • The key companies covered in this study include Agilent Technologies, Thermo Fisher Scientific, SGS S.A., Shimadzu Corp, Waters Corp., Bio-Rad Laboratories, Bruker Corporation, Charles River Laboratories, Selvita, and Rapid Novor Inc.
  • The report enables marketers and management authorities to make informed decisions regarding future product launches, market expansion, and marketing tactics.
  • Various stakeholders in the protein sequencing industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts, can benefit from the insights provided.
  • Strategy matrices used in analyzing the global protein sequencing market will assist stakeholders in making informed decisions.

Protein Sequencing Market Segmentation:

  • By Technology¬
    • Edman Degradation
    • Mass Spectrometry
    • Others
  • By Product
    • Instruments
    • Reagents, Kits & Consumables
    • Software & Services
  • By Application
    • Academic Research
    • Clinical Diagnosis
    • Biopharmaceuticals
    • Others
  • By End user
    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • Contract Research Organizations
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Top Companies in Protein Sequencing Market:
    • Agilent Technologies
    • Thermo Fisher Scientific
    • SGS S.A.
    • Shimadzu Corp
    • Waters Corp.
    • Bio-Rad Laboratories
    • Bruker Corporation
    • Charles River Laboratories
    • Selvita
    • Rapid Novor Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Protein Sequencing, By Technology
    • Market Protein Sequencing, By Product
    • Market Protein Sequencing, By Application
    • Market Protein Sequencing, By End user
    • Market Protein Sequencing, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Increasing investments in proteomics research
    • Restraints
    • High costs of protein sequencing instruments and services
    • Opportunities
    • Significant growth opportunities exist in emerging economies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Protein Sequencing Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Protein Sequencing Market, By Technology, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Edman Degradation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Mass Spectrometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Protein Sequencing Market, By Product, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Reagents, Kits & Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Software & Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

7. Protein Sequencing Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Academic Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Clinical Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Biopharmaceuticals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

8. Protein Sequencing Market, By End user, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

9. Protein Sequencing Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019 - 2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.K
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Agilent Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
  • SGS S.A.
  • Shimadzu Corp
  • Waters Corp.
  • Bio-Rad Laboratories
  • Bruker Corporation
  • Charles River Laboratories
  • Selvita
  • Rapid Novor Inc.
  • Analyst Views

11. Section

  • Research Methodology
  • About us